Ten years with New Delhi metallo-β-lactamase-1 (NDM-1): from structural insights to inhibitor design

P Linciano, L Cendron, E Gianquinto… - ACS infectious …, 2018 - ACS Publications
The worldwide emergence of New Delhi metallo-β-lactamase-1 (NDM-1) as a
carbapenemase able to hydrolyze nearly all available β-lactam antibiotics has characterized …

Low-dimensional nanomaterials for antibacterial applications

XL Hu, Y Shang, KC Yan, AC Sedgwick… - Journal of Materials …, 2021 - pubs.rsc.org
The excessive use of antibiotics has led to a rise in drug-resistant bacteria. These
“superbugs” are continuously emerging and becoming increasingly harder to treat. As a …

Discovery of metal-binding proteins by thermal proteome profiling

X Zeng, T Wei, X Wang, Y Liu, Z Tan, Y Zhang… - Nature Chemical …, 2024 - nature.com
Metal-binding proteins (MBPs) have various and important biological roles in all living
species and many human diseases are intricately linked to dysfunctional MBPs. Here, we …

[HTML][HTML] Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates

B Zhao, X Zhang, T Yu, Y Liu, X Zhang, Y Yao… - … Pharmaceutica Sinica B, 2021 - Elsevier
New Delhi metallo-β-lactamase-1 (NDM-1) is capable of hydrolyzing nearly all β-lactam
antibiotics, posing an emerging threat to public health. There are currently less effective …

Gliotoxin-mediated bacterial growth inhibition is caused by specific metal ion depletion

SG Downes, RA Owens, K Walshe, DA Fitzpatrick… - Scientific Reports, 2023 - nature.com
Overcoming antimicrobial resistance represents a formidable challenge and investigating
bacterial growth inhibition by fungal metabolites may yield new strategies. Although the …

[HTML][HTML] The development of New Delhi metallo-β-lactamase-1 inhibitors since 2018

X Gu, M Zheng, L Chen, H Li - Microbiological Research, 2022 - Elsevier
New Delhi metallo-β-lactamase-1 (NDM-1) can hydrolyze almost all antibiotics of the β-
lactam group, resulting in the generation of multidrug resistant bacteria. Besides its broad …

Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1)

KCN Venkata, M Ellebrecht, SK Tripathi - European journal of medicinal …, 2021 - Elsevier
Antimicrobial stewardship is imperative when treating bacterial infections because the
misuse and overuse of antibiotics have caused pathogens to develop life-threatening …

A cephalosporin prochelator inhibits New Delhi metallo-β-lactamase 1 without removing zinc

AC Jackson, JM Zaengle-Barone… - ACS infectious …, 2020 - ACS Publications
Antibacterial drug resistance is a rapidly growing clinical threat, partially due to expression
of β-lactamase enzymes, which confer resistance to bacteria by hydrolyzing and inactivating …

[HTML][HTML] Approachable Synthetic Methodologies for Second-Generation β-Lactamase Inhibitors: A Review

N Fatima, S Khalid, N Rasool, M Imran, B Parveen… - Pharmaceuticals, 2024 - mdpi.com
Some antibiotics that are frequently employed are β-lactams. In light of the hydrolytic
process of β-lactamase, found in Gram-negative bacteria, inhibitors of β-lactamase (BLIs) …

H2dpa derivatives containing pentadentate ligands: An acyclic adjuvant potentiates meropenem activity in vitro and in vivo against metallo-β-lactamase-producing …

F Chen, M Bai, W Liu, H Kong, T Zhang, H Yao… - European Journal of …, 2021 - Elsevier
The emergence and dissemination of metallo-β-lactamases (MBLs) producing
Enterobacterales is a great concern for public health due to the limited therapeutic options …